Watch tonight’s video market recap on my Ticker.tv channel, Mark333.Indexes continued their rotten start to 2015 as the S&P 500 fell 0.89% and the NASDAQ 1.29%. Markets opened up and then sellers came in which is not the type of action you want to see during a bull market move – you want the opposite (morning weakness bought!). Oil continues […]
View gallery.Many biotech stocks have been breaking out over the past two months.Newlink Genetics Corp and Incyte Corporation both skyrocketed in October.After that, stocks of Ariad Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. both had nice, quick pops last month.Then there was Kite Pharma Inc’s huge jump earlier this month.
So, Who’s Next?
The Company: Sangamo Biosciences, Inc.Ticker Symbol: (NASDAQ: SGMO)Sector: HealthcareIndustry: BiotechnologySangamo focuses on the research, development and […]
Two Biotech Stocks Set to Double on One Powerful CatalystCompanies / BioTechNov 21, 2014 – 02:46 PM GMTBy: Money_MorningWilliam Patalon writes: When I earned my MBA from the Rochester Institute of Technology (RIT) back in the mid-1990s, my focus was finance and investing.But it was a management professor who clued me in to some of the best ways to “look […]
REUTERS/Yuya Shino”2,200? That’s it?”See AlsoCiti Raises Its 2014 Target And Unveils Its 2015 Target For The S&P 500This Definitive Chart Destroys The Argument That We’re Reliving The Bubble Of The Late 1990sThe S&P Closed At A Record 2,039 On Friday — Here’s What Wall Street Predicted In JanuaryCiti’s Tobias Levkovich and his equity strategy were recently in Asia for client […]
AP ImagesThe Ibis T5000(TM) Biosensor SystemISIS, or the Islamic State of Iraq and Syria, has gotten lots of attention for the terror it has brought to the Middle East.
Unfortunately, this has attracted the wrong kind of attention to companies that coincidentally share the same name as the extremist group.Take ISIS Pharmaceuticals. This $4.3 billion biotech firm surged 10% today, and […]
Welcome to our daily roundup of top insider trades. Here’s a look at the most significant inside purchases recently filed with the SEC.Notable Purchases:
The billionaire activist investor Carl Icahn, a beneficial owner of commercial and military truck company Navistar International (NYSE:NAV), bought 1,027,789 shares of company stock for $34,205,404.
The venture capital firm Polaris Venture Management bought 1,470,582 shares of clinical-stage oncology-focused company Cerulean Pharmaceuticals (NASDAQ:CERU) […]
